Keyphrases
Non-small Cell Lung Cancer (NSCLC)
100%
Fluorodeoxyglucose Positron Emission Tomography (FDG-PET)
100%
Metastatic Disease
100%
Brain PET
40%
Brain MRI
40%
Negative Findings
40%
Whole-body
20%
Overall Survival
20%
Clinical Management
20%
Disease-free Survival
20%
FDG Uptake
20%
18F-fluorodeoxyglucose (18F-FDG)
20%
18F-fluorodeoxyglucose Positron Emission Tomography (18F-FDG PET)
20%
Sufficient Follow-up
20%
American College of Surgeons Oncology Group
20%
Brain Imaging
20%
Brain Abnormalities
20%
Brain CT
20%
Intracranial Metastases
20%
Staging Procedures
20%
Dedicated PET
20%
Medicine and Dentistry
Positron Emission Tomography
100%
Non Small Cell Lung Cancer
100%
Metastatic Carcinoma
66%
Magnetic Resonance Imaging
33%
Fluorodeoxyglucose F 18
33%
Surgeon
11%
Overall Survival
11%
Oncology
11%
Clinical Management
11%
Disease Free Survival
11%
Brain Imaging
11%
Brain Abnormalities
11%
Neuroscience
Positron Emission Tomography
100%
Magnetic Resonance Imaging
33%
Fluorine-18
33%
Brain Imaging
11%
Brain Abnormalities
11%